Teva Pharmaceutical (TEVA)
NYSE:TEVA
Holding TEVA?
Track your performance easily

Teva Pharmaceutical (TEVA) Ownership - Who Owns Teva Pharmaceutical?

6,680 Followers

Teva Pharmaceutical (TEVA) Ownership Overview

0.65%17.47%34.84%47.04%
34.84% Other Institutional Investors
― ETFs
47.04% Public Companies and Individual Investors
The ownership structure of Teva Pharmaceutical (TEVA) stock is a mix of institutional, retail, and individual investors. , 0.65% is owned by Insiders, and 47.04% is owned by Public Companies and Individual Investors.
The ownership structure of {name} ({ticker}) stock is a mix of institutional, retail, and individual investors. {displayInstitutionalData, select, display {Approximately {institutionalPercentage} of the company’s stock is owned by Institutional Investors} other {}}{displayInsiderText, select, display {, {insidersPercentage} is owned by Insiders} other {}}{displayInvestorsText, select, display {, and {retailInvestorsPercentage} is owned by Public Companies and Individual Investors.} other {}}

Recent Insider Trading Activity

Date
Name
Activity
Value
Aug 13, 2024
Richard Daniell
Exec. Vp, European Commercial
xxxxxxxxxxxxx
$1710724
Aug 13, 2024
Eric A Hughes
Evp, Global R&d And Chief Medical Officer
xxxxxxxxxxxxx
$782692
Jun 21, 2024
xxxxxxxxxxxxx
$8838570
May 17, 2024
xxxxxxxxxxxxx
$470773

Recent Hedge Fund Trading Activity

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
58,734,848Institution5.18%1,028,447,188
39,840,286Institution3.52%697,603,408
23,274,494Institution2.05%407,536,390
20,191,184Institution1.78%353,547,632
17,949,245Institution1.58%314,291,280
14,000,000Institution1.24%245,140,000
13,666,077Institution1.21%239,293,008
9,157,641Institution0.81%160,350,294
8,496,612Institution0.75%148,775,676
6,727,432Institution0.59%117,797,334

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
58,734,848Institution5.18%1,028,447,188
39,840,286Institution3.52%697,603,408
17,949,245Institution1.58%314,291,280
14,000,000Institution1.24%245,140,000
13,666,077Institution1.21%239,293,008
6,727,432Institution0.59%117,797,334
5,007,700Institution0.44%87,684,827
4,480,040Institution0.40%78,445,500
3,500,000Institution0.31%61,285,000
3,454,169Institution0.30%60,482,499

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
6,897,159Institution0.61%122,493,544
3,697,089Institution0.33%65,660,301
2,481,856Institution0.22%44,077,763
1,414,019Institution0.12%25,112,977
1,403,304Institution0.12%24,922,679
1,334,992Institution0.12%23,709,458
955,900Institution0.08%16,976,784
955,900Institution0.08%16,976,784
955,900Institution0.08%16,976,784
936,422Institution0.08%16,630,855

FAQ

Who Owns Teva Pharmaceutical (TEVA)?
According to the latest TipRanks data, approximately 34.84% of the company's stock is held by institutional investors, 0.65% is held by insiders, and 47.04% is held by retail investors.
    What percentage of Teva Pharmaceutical (TEVA) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 34.84% of Teva Pharmaceutical (TEVA) stock is held by institutional investors.
      What percentage of Teva Pharmaceutical (TEVA) stock is held by retail investors?
      According to the latest TipRanks data, approximately 47.04% of Teva Pharmaceutical (TEVA) stock is held by retail investors.
        Who owns the most shares of Teva Pharmaceutical (TEVA)?
        Growth Fund of America owns the most shares of Teva Pharmaceutical (TEVA).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis